IC
NRC icon

Innealta Capital’s NRC Health Common Stock NRC Stock Holding History

Innealta Capital’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25
Closed -$574 – 1151
2024
Q2 		$574 Buy
+25
New +$771 ﹤0.01% 1447

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Innealta Capital's NRC Position: Q3 2024 in Review

Innealta Capital sold out of NRC Health Common Stock (NRC) in Q3 2024, closing a stake of 25 shares — an estimated $574 sold.

Innealta Capital first reported a position in NRC in Q2 2024 and held it in 1 quarter. The position peaked at $574 in Q2 2024. 138 funds tracked by Wall St. Rank hold NRC as of Q3 2024.

  • Innealta Capital reported no remaining NRC Health Common Stock position as of Q3 2024 after selling out during the quarter.
  • Innealta Capital sold 25 NRC Health Common Stock shares in Q3 2024, an estimated $574.
  • Innealta Capital first reported a position in NRC Health Common Stock in Q2 2024 and held it in 1 quarter.
  • Innealta Capital's NRC Health Common Stock position peaked at $574 in Q2 2024.
  • 138 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.